WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Anticonvulsant-CMAP-v8_final.cmap, Potential exacerbation of pre-existing seizures documents Seizure occurrence, Seizure type has_values Partial seizure, Treatment Phase includes Titration period, Repeated concepts/instances (e.g. Seizure occurrence) are denoted by dotted outline, FDA Efficacy Endpoints for Anticonvulsant Therapies include Secondary efficacy endpoint, Observation time phase is_documented_in Seizure diary, Primary efficacy endpoints (e.g. Seizure frequency) are denoted by bold font, Therapeutic Efficacy Endpoint are characterized by Observations or Assessments, Observation time phase has_component Baseline phase, Primary efficacy endpoint documents Time to meeting exit criteria*, Primary efficacy endpoint documents Seizure frequency, Partial seizure refers_to Partial seizure subtype, FDA Efficacy Endpoints for Anticonvulsant Therapies include Primary efficacy endpoint, Seizure count is_documented_in Seizure diary, Time to meeting exit criteria* occurs_over Observation time phase, Concepts (e.g. Seizure diary) are denoted by solid round-edged rectangle, Development of new seizure types documents Seizure occurrence, Seizure frequency occurs_over Observation time phase, Secondary efficacy endpoint documents Other endpoints in seizure frequency domain, Seizure frequency has_component Seizure count